<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00887523</url>
  </required_header>
  <id_info>
    <org_study_id>2009/184</org_study_id>
    <nct_id>NCT00887523</nct_id>
  </id_info>
  <brief_title>Trial Comparing Prone and Supine Intensity-modulated Radiotherapy (IMRT) After Breast-conserving Surgery in Patients With Large Breast Volume at High Risk for Skin Toxicity and Fibrosis</brief_title>
  <official_title>Randomized Controlled Trial Comparing Prone and Supine Intensity-modulated Radiotherapy (IMRT) After Breast-conserving Surgery in Patients With Large Breast Volume at High Risk for Skin Toxicity and Fibrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Plan, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      84 patients with a cup size C or more will be randomized to receive intensity-modulated
      radiotherapy in supine or prone position.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2009</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>acute moist desquamation</measure>
    <time_frame>weekly during radiotherapy and 1 month after radiotherapy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acute skin toxicity other than moist desquamation</measure>
    <time_frame>weekly during radiotherapy and 1 month after radiotherapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late skin toxicity</measure>
    <time_frame>at 6, 12, 18 and 24 months after radiotherapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>skin and lung fibrosis assessed with computed tomography</measure>
    <time_frame>before radiotherapy and 1 month and 1 year after radiotherapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>at 1 year and 2 years after radiotherpay</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dose-volume parameters</measure>
    <time_frame>of planning</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time of treatment delivery</measure>
    <time_frame>daily during radiotherapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>single nucleotide polymorphisms associated with skin toxicity and breast fibrosis</measure>
    <time_frame>1 blood sample before radiotherapy</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Breast Carcinoma</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>prone intensity-modulated radiotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>supine intensity-modulated radiotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>radiation in prone position</intervention_name>
    <description>radiation in prone position</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>radiation in supine position</intervention_name>
    <description>radiation in supine position</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  female patients

          -  multidisciplinary decision of adjuvant whole-breast irradiation (WBI) after lumpectomy
             for breast cancer

          -  minimum 18 years

          -  informed consent obtained, signed and dated before specific protocol procedures

        Exclusion Criteria:

          -  mastectomy

          -  need for axillary irradiation

          -  bilateral breast irradiation

          -  previous irradiation at the same time

          -  mental condition rendering the patient unable to understand the nature, scope and
             possible consequences of the study

          -  patient unlikely to comply with the protocol; i.e. uncooperative attitude, inability
             to return for follow-up visits, and unlikely to complete the study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wilfried De Neve, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Ghent</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Liv Veldeman</last_name>
    <email>liv.veldeman@uzgent.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Ghent</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wilfried De Neve, MD, PhD</last_name>
      <email>wilfried.deneve@uzgent.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>http://www.uzgent.be</url>
    <description>website of the University Hospital Ghent</description>
  </link>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2009</study_first_submitted>
  <study_first_submitted_qc>April 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 24, 2009</study_first_posted>
  <last_update_submitted>June 2, 2015</last_update_submitted>
  <last_update_submitted_qc>June 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

